Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Shilpa Medicare Limited
SHILPAMED | NSE
374.70
INR25.80
7.39%
SHILPAMED | NSE
Loading StockChartView...
About Shilpa Medicare Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
374.70
Open
360.00
High
379.10
Low
350.60
Shilpa Medicare Limited together with its subsidiaries engages in the manufacturing and selling active pharmaceutical ingredients (APIs) intermediates and formulations in India the United States Europe and internationally. It's primary oncology and non-oncology APIs include capecitabine gemcitabine hydrochloride axitinib erlotinib hydrochloride and irinotecan hydrochloride as well as ambroxol tranexmic acid and ursodeoxycholic acid; and new drug delivery systems peptides/biotech products specialty chemicals etc. The company also provides contract manufacturing of various dosage forms such as tablets capsules liquid injections lyophilized injectables and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur India.
View LessSHILPAMED | NSE
Risk
55.2
Sharpe
0.12
Luna's Score
52/100
Recommendation
Hold
Luna says (SHILPAMED | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Smallcap (300M - 2B USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
63.4%1 month
55.2%3 months
43.6%6 months
37.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
172.28
Fwd. PE
196.08
Price to book
4.67
Debt to equity
0.52
Debt to assets
0.30
Ent. to EBITDA
37.98
Ent. to rev.
8.12
PEG
-
Other Fundamentals
EBITDA
2.74B
MarketCap
37.00B
MarketCap(USD)
397.09M
Div. yield
-
Op. margin
15.89
Erngs. growth
942.90
Rev. growth
12.40
Ret. on equity
1.79
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
68.05
Range1M
70.80
Range3M
119.60
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.75
Price X volume
288.92M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 37.98 | 24.85 | Expensive |
| Ent. to Revenue | 8.12 | 11.40 | Cheaper |
| PE Ratio | 172.28 | 51.36 | Expensive |
| Price to Book | 4.67 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 43.56 | 42.17 | Par |
| Debt to Equity | 0.52 | 0.35 | Expensive |
| Debt to Assets | 0.30 | 0.17 | Expensive |
| Market Cap | 37.00B | 290.82B | Emerging |
